Vai al contenuto principale
Faslodex (Fulvestrant) 250 mg – Hormonal Therapy for Breast Cancer  Faslodex (Fulvestrant) - Macrocare Health Blog

Faslodex (Fulvestrant) 250 mg – Hormonal Therapy for Breast Cancer Faslodex (Fulvestrant)

Faslodex (Fulvestrant) is a hormonal therapy used in the treatment of HR-positive breast cancer, particularly in advanced or metastatic cases. It helps slow the growth of cancer cells that depend on estrogen.

 

What is Faslodex (Fulvestrant)?

Faslodex belongs to a class of drugs known as Estrogen Receptor Antagonists.

Some types of breast cancer rely on estrogen to grow and spread. Faslodex works by:

  • Blocking estrogen receptors in cancer cells
  • Reducing the effect of estrogen on tumors
  • Slowing cancer growth and progression

In simple terms:
It prevents cancer cells from using estrogen to grow.

 

Indications

Faslodex (Fulvestrant) is used in:

  • HR-positive breast cancer
  • Advanced or metastatic disease
  • Cases previously treated with hormonal therapy
  • Combination therapy with targeted agents such as CDK4/6 inhibitors
 

Dosage and Administration

  • Standard dose: 250 mg or according to treatment protocol
  • Administered as an intramuscular injection
  • Injection schedule is determined by the physician
  • May be used alone or in combination with other therapies
 

Common Side Effects

May include:

  • Injection site pain
  • Hot flashes
  • Nausea
  • Fatigue
  • Joint or muscle pain
  • Headache

These side effects are usually manageable with proper monitoring.

 

Monitoring During Treatment

Patients on Faslodex (Fulvestrant) require:

  • Assessment of tumor response
  • Symptom evaluation
  • Liver function monitoring when needed
  • Regular imaging and follow-up examinations
 

Availability & How to Access Treatment

Faslodex (Fulvestrant) is available through Macrocare’s approved partners.

You can now request and access the medication easily through us.

WhatsApp contact for medication requests:
Click here

 

 

Faslodex (Fulvestrant) Faslodex (Fulvestrant) 250 mg is an effective hormonal therapy that helps slow the progression of HR-positive breast cancer by blocking estrogen activity in cancer cells.

 

Medical Disclaimer:
This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.

 
 

Inserisci il numero di cellulare

Condividi il tuo numero di telefono così possiamo contattarti per conoscere il tuo disturbo di salute.

Privacy protetta: le tue informazioni mediche e personali sono mantenute completamente riservate e protette con standard di sicurezza di livello industriale.

CONTATTACI

Contattaci

Condividi il tuo numero di telefono così possiamo contattarti per conoscere il tuo disturbo di salute.

Linea diretta

+20 106 604 2282

Chiama

Indirizzo email

[email protected]

Scrivi